Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2023-46810

22
FAUCET Score

CVE-2023-46810 is a local privilege escalation vulnerability affecting Ivanti Secure Access Client for Linux versions prior to 22.7R1, allowing a low-privileged user to execute code as root. With a CVSS score of 7.3 (HIGH), this vulnerability has a local attack vector, low attack complexity, and high impacts on confidentiality, integrity, and availability. There is no evidence of active exploitation, nor is public exploit code available in Metasploit, Nuclei, or ExploitDB. Community discussion and media coverage for this CVE are currently minimal.

Impacted Technologies

VendorProductVersion(s)CPE
< 22.7CPE matchmatch criteria
cpe:2.3:a:ivanti:secure_access_client:*:*:*:*:*:*:*:*

CVSS Data

CVSS version used by this source: 3.0

7.3HIGH

CVSS:3.0/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H

Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
REQUIRED
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
HIGH
Availability Impact
HIGH
Exploitability Score
1.3
Impact Score
5.9
CvssVersion
3.0

Exploit Intelligence

EPSS Score
0.31%
Probability of exploitation in next 30 days
EPSS Percentile
23.3%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0031 is in the 57th percentile among its peer group of 759 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.1 Bluesky, 0.0 Mastodon, and 0.1 GitHub mentions.

Media Mentions

No media coverage found for this CVE.

The average CVE in this peer group has 0.2 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Vendor Patches (1)

ivantivendor investigatingvia nvd_reference
View patch

References

forums.ivanti.com / s/article/Security-Advisory-May-2024
Vendor Advisory